1,081 results on '"Le Grand, Roger"'
Search Results
2. MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates
3. Seminal plasma inhibits Chlamydia trachomatis infection in vitro, and may have consequences on mucosal immunity
4. Fetal Zika virus inoculation in macaques revealed control of the fetal viral load during pregnancy
5. Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging
6. Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques
7. Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2
8. Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells
9. SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells
10. A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens
11. Identification of macaque dendritic cell precursors in blood and tissue reveals their dysregulation in early SIV infection
12. Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure
13. In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting
14. Intestinal immunological events of acute and resolved SARS-CoV-2 infection in non-human primates
15. Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics
16. Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys
17. Preclinical development and pharmacokinetic assessment in macaques of a multipurpose long-acting injectable suspension containing medroxyprogesterone acetate for contraception and rilpivirine for HIV prevention
18. Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model
19. Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques
20. SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19
21. Improving in vitro continuous cultivation of Plasmodium cynomolgi, a model for P. vivax
22. Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates
23. Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection
24. Impact of a PMMA tube on performances of a Vereos PET/CT system adapted for BSL-3 environment according to the NEMA NU2-2012 standard
25. Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
26. Detection of SARS-CoV-2 in subcutaneous fat but not visceral fat, and the disruption of fat lymphocyte homeostasis in both fat tissues in the macaque
27. Intranasal inoculation with Bordetella pertussis confers protection without inducing classical whooping cough in baboons
28. Recombinant myelin oligodendrocyte glycoprotein quality modifies evolution of experimental autoimmune encephalitis in macaques
29. NK-B cell cross talk induces CXCR5 expression on natural killer cells
30. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
31. Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
32. Non-human primate models of human respiratory infections
33. Role of NKG2a/c+CD8+ T cells in pathogenic versus non-pathogenic SIV infections
34. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
35. An Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism.
36. Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.
37. Multiple Mechanisms of Action of Sulfodyne ® , a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection.
38. Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study
39. Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination
40. Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics
41. Animal models for COVID-19
42. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
43. Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates
44. Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls
45. SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity
46. Leukocytospermia induces intraepithelial recruitment of dendritic cells and increases SIV replication in colorectal tissue explants
47. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
48. A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
49. HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry
50. Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.